General Information of the Compound
Compound ID |
CP0386343
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
Thebaine
Show/Hide
|
||||||||||||||||||
Synonyms |
(5R,9R,13S)-4,5-Epoxy-3,6-dimethoxy-9alpha-methyl-6,8-morphinadien
115-37-7
2P9MKG8GX7
3,6-dimethoxy-17-methyl-6,7,8,14-tetradehydro-4,5alpha-epoxymorphinan
3-O-Methyl-oripavin
4,5alpha-Epoxy-3,6-dimethoxy-17-methyl-6,8-morphinadien
CHEBI:9519
DEA No. 9333
DSSTox_CID_26099
DSSTox_GSID_46099
DSSTox_RID_81337
EINECS 204-084-1
Morphinan, 6,7,8,14-tetradehydro-4,5-alpha-epoxy-3,6-dimethoxy-17-methyl-
NCGC00160239-01
Paramorphine
THEBAINE
Thebain
UNII-2P9MKG8GX7
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C19H21NO3
|
||||||||||||||||||
Molecular Weight |
311.381
|
||||||||||||||||||
Canonical SMILES |
COC1=CC=C2[C@H]3Cc4ccc(OC)c5O[C@@H]1[C@]2(CCN3C)c45
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C19H21NO3/c1-20-9-8-19-12-5-7-15(22-3)18(19)23-17-14(21-2)6-4-11(16(17)19)10-13(12)20/h4-7,13,18H,8-10H2,1-3H3/t13-,18+,19+/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
FQXXSQDCDRQNQE-VMDGZTHMSA-N
|
||||||||||||||||||
CAS |
115-37-7
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound